Applying to LLM-BRIDGE Venture Incubation 2026

Clinician-supervised LLM layer for premium longevity clinics.

VitaBridge AI turns medical reports, biomarker data and clinic protocols into reviewed, member-ready action plans — replacing static PDFs with a secure dashboard and a doctor-in-the-loop workflow.

Founded
LVC, Schaan (LI)
First pilot
South Tyrol
MVP horizon
12 weeks
VitaBridge AI bridges medical reports and clinician-approved action plans

Clinician-approved output

No autonomous diagnosis · EU hosted

The problem

Premium clinics still communicate longevity through static documents.

Members pay for orientation, discretion and visible progress — yet the communication layer between complex diagnostics and daily action is still PDFs, lab reports and one-off explanations. This is an operational and experiential bottleneck in a high-value segment.

Static PDFs

Lab results and protocols arrive as documents that hide what changed and why it matters.

Repeated explanations

Clinic teams spend premium hours re-explaining the same biomarker context to each member.

Invisible progress

Members rarely see a clear path from current state to the target agreed with the clinic.

Adherence drift

Without continuous nudges, individual protocols silently lose traction between visits.

The product

Two surfaces. One controlled workflow.

A retrieval-grounded LLM agent sits between clinic-approved knowledge and the member experience — and every output passes a clinician.

For members

Member dashboard

  • Plain-language explanations of complex medical reports
  • Biomarker changes with target state agreed with the clinic
  • Protocol progress and daily / weekly next steps
  • Member questions prepared ahead of the next consult

For clinicians

Review & approval workspace

  • Upload reports, structure data, manage approved protocols
  • Review LLM-generated explanations before members see them
  • Approve, correct or override every member-facing output
  • Immutable audit trail of generated, reviewed and approved content
How it works

From medical report to approved action plan

01

Ingest

Lab reports, biomarker series and clinic-approved protocols are structured into a member-specific knowledge base.

02

Generate

A retrieval-augmented LLM drafts explanations and next steps, grounded in approved sources with citations.

03

Review

The clinician approves, edits or rejects every draft. Nothing reaches the member without a doctor-in-the-loop.

04

Engage

Members see clear progress, target state and weekly actions — with adherence tracked back to the clinic.

Responsible AI

Built for a sensitive domain — and for European rules.

We treat privacy, medical responsibility and AI governance as product requirements, not afterthoughts.

Clinician-in-the-loop by design

Member-facing recommendations require explicit clinician approval. No autonomous diagnosis or treatment advice.

Retrieval grounded in approved sources

Every generated explanation is anchored in clinic-approved knowledge with source citations and audit trail.

European, privacy-preserving stack

EU hosting, GDPR-aligned data flows, model-agnostic architecture — ready to evaluate privacy-preserving European LLMs.

Clear regulatory boundary

Positioned as a communication and coaching layer — explicitly outside autonomous medical decision-making. EU AI Act and MDR boundary validated during the programme.

Market & business model

A narrow first market — with a clear European expansion path.

We start where the pain is most acute and willingness-to-pay is highest: premium longevity and preventive health clinics in Europe. Recurring diagnostics, high member value and complex protocols make this the right beachhead for a clinician-supervised LLM layer.

Model

B2B SaaS & clinic licensing

Pricing

Setup + monthly + per active member

Deployment

White-label per clinic

Pilot context

Private clinic, South Tyrol

Segment ladder

  • 01Premium longevity clinics
    Beachhead
  • 02Preventive medicine centres
    Adjacent
  • 03Executive health providers
    Adjacent
  • 04Sports medicine & performance
    Expansion
  • 05High-end rehabilitation
    Expansion
12-week incubation plan

A focused MVP — demonstrable on Demo Day

Six phases. One pilot pathway. A single member journey from complex report to clinician-approved action plan.

Weeks 1–2PHASE 01

Scope & risk boundary

  • ·Select one narrow pilot pathway
  • ·Map data categories and privacy risks
  • ·Decide model and hosting architecture
Weeks 3–4PHASE 02

Knowledge base & data model

  • ·Build first clinic-approved knowledge base
  • ·Define report & protocol data fields
  • ·First retrieval and prompt flows
Weeks 5–7PHASE 03

Member experience

  • ·Member dashboard with report explanation
  • ·Biomarker progress view
  • ·Protocol-based next steps (synthetic data)
Weeks 8–9PHASE 04

Clinician workspace

  • ·Review, approval & override workflow
  • ·Audit trail and protocol management
  • ·Clinician-in-the-loop end-to-end
Weeks 10–11PHASE 05

Validation

  • ·Clinic usability & compliance test
  • ·Business model and pricing validation
  • ·Investor and Demo Day narrative
Week 12PHASE 06

Final demo & funding step

  • ·One full member journey demo
  • ·Pilot proposal for first clinic
  • ·Investor-ready narrative & funding ask

Use of the €25,000 support

Privacy & regulatory review · secure hosting · medical domain review · UX refinement · pilot preparation.

Tied to validation milestones
Team

Founders with venture, AI and clinic-access experience.

VitaBridge AI is incorporated as a Liechtenstein Venture Cooperative (LVC) in Schaan — a structure designed for IP, know-how and capital contributions to live under one roof.

JT

Julian Thuile

Co-founder · Commercial & Customer Discovery

Venture builder and B2B operator. Co-founder of LEAD Horizon (nine-figure ARR, successful exit). Currently leads dockyard, focused on new-market development for B2B in DACH.

HH

Hartmut Hübner

Co-founder · AI Architecture & Responsible AI

Co-Founder of MMIND.ai (Schaan). Builds AI knowledge bases, MCP tooling, Claude Skills, Dify and secure infrastructure for SMEs. Senior B2B communications background (Siemens Financial Services, Deutsche Börse).

EM

Eva Marie Mühlberger

Co-founder · Operations & Programme Execution

Owns operations, validation process and commercial packaging for the 12-week programme. Profile detail to be added to the final submission.

Why LLM-BRIDGE should select us

Specific enough to validate in 12 weeks. Ambitious enough to scale across Europe.

Real LLM workflow
A retrieval-grounded agent for a specific operational bottleneck — not a generic chatbot.
Premium B2B market
High-value European clinics with recurring diagnostics and clear willingness to pay.
Responsible AI boundary
Clinician-in-the-loop by design. Explicit AI Act / MDR positioning from day one.
European strategic relevance
EU hosting, GDPR-aligned, model-agnostic — ready for European LLM evaluation.
12-week demo-able
MVP scope narrow enough to show one full member journey on Demo Day.

For evaluators · clinics · partners

Request the VitaBridge AI pilot brief.

Two pages: pilot pathway, technical architecture, responsible-AI boundary, and the use of the €25,000 LLM-BRIDGE support tied to concrete milestones.